Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Keyser

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
BMJ (Clinical Research Ed.)|April 25, 2000
Worsening of symptoms of multiple sclerosis associated with carbamazepineG Ramsaransing, C Zwanikken, J De Keyser
European Journal of Neurology|July 31, 2007
Predictive value of clinical characteristics for 'benign' multiple sclerosisG S M Ramsaransing, J De Keyser
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Timing of birth and disease progression in multiple sclerosisM Koch, J De Keyser, H Tremlett
Trends in Neurosciences|November 5, 1999
Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?J De Keyser, G Sulter, P G Luiten
American Journal of Ophthalmology|April 15, 1991
Vertebral artery occlusion complicating perimetryJ De Keyser, L Herroelen, L Van Langenhove
Neuroscience Letters|October 1, 1998
Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic strokeG Sulter, J W Elting, J De Keyser
Acta Neurologica Belgica|November 5, 1997
Is positron emission tomography useful in stroke?J De Reuck, D Leys, J De Keyser
Current Topics in Medicinal Chemistry|October 24, 2009
Thrombolysis for acute ischemic strokeM Uyttenboogaart, J De Keyser, G J Luijckx
Gynecologic and Obstetric Investigation|January 25, 2013
Female gender and reproductive factors affecting risk, relapses and progression in multiple sclerosisM B D'hooghe, T D'Hooghe, J De Keyser
Journal of the Neurological Sciences|January 1, 1997
Early outcome in acute ischemic stroke is not influenced by the prophylactic use of low-dose aspirinJ De Keyser, L Herroelen, N De Klippel
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
BMJ (Clinical Research Ed.)|April 25, 2000
Worsening of symptoms of multiple sclerosis associated with carbamazepineG Ramsaransing, C Zwanikken, J De Keyser
European Journal of Neurology|July 31, 2007
Predictive value of clinical characteristics for 'benign' multiple sclerosisG S M Ramsaransing, J De Keyser
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Timing of birth and disease progression in multiple sclerosisM Koch, J De Keyser, H Tremlett
Trends in Neurosciences|November 5, 1999
Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?J De Keyser, G Sulter, P G Luiten
American Journal of Ophthalmology|April 15, 1991
Vertebral artery occlusion complicating perimetryJ De Keyser, L Herroelen, L Van Langenhove
Neuroscience Letters|October 1, 1998
Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic strokeG Sulter, J W Elting, J De Keyser
Acta Neurologica Belgica|November 5, 1997
Is positron emission tomography useful in stroke?J De Reuck, D Leys, J De Keyser
Current Topics in Medicinal Chemistry|October 24, 2009
Thrombolysis for acute ischemic strokeM Uyttenboogaart, J De Keyser, G J Luijckx
Gynecologic and Obstetric Investigation|January 25, 2013
Female gender and reproductive factors affecting risk, relapses and progression in multiple sclerosisM B D'hooghe, T D'Hooghe, J De Keyser
Journal of the Neurological Sciences|January 1, 1997
Early outcome in acute ischemic stroke is not influenced by the prophylactic use of low-dose aspirinJ De Keyser, L Herroelen, N De Klippel
Pageof 18